AF-MSCs from second- and third-trimester (16–28 weeks) expressed comparable levels of Oct-4 and Nanog, while some difference in the expression levels of Sox-2 and Rex-1 was related to the gestational age. The gene discussed is NANOG; the disease is atrial fibrillation.